S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?

Emergent BioSolutions (EBS) News Today

$3.20
-0.10 (-3.03%)
(As of 02/28/2024 ET)
SourceHeadline
seekingalpha.com logoNew CEO Appointment A Clear Positive For Emergent BioSolutions
seekingalpha.com - February 27 at 3:06 PM
marketbeat.com logoEmergent BioSolutions (EBS) Set to Announce Quarterly Earnings on Monday
marketbeat.com - February 25 at 7:32 AM
MarketBeat logoEmergent BioSolutions (NYSE:EBS) Stock Price Crosses Above 200-Day Moving Average of $2.81
americanbankingnews.com - February 24 at 4:00 AM
bizjournals.com logoBiotech with Baltimore facility taps new CEO
bizjournals.com - February 21 at 6:59 PM
investorplace.com logoWhy Is Emergent BioSolutions (EBS) Stock Up 70% Today?
investorplace.com - February 21 at 4:07 PM
investorplace.com logoWhy Is Emergent BioSolutions (EBS) Stock Up 70% Today?
investorplace.com - February 21 at 3:24 PM
msn.com logoTeladoc Health, Avinger among healthcare movers
msn.com - February 21 at 1:58 PM
markets.businessinsider.com logoEmergent BioSolutions Gains 95% Following Announcement Of Joseph Papa As New CEO
markets.businessinsider.com - February 21 at 1:58 PM
reuters.com logoEmergent names Joseph Papa as new CEO
reuters.com - February 21 at 8:58 AM
finance.yahoo.com logoUPDATE 1-Emergent appoints former Bausch + Lomb CEO to head company
finance.yahoo.com - February 21 at 8:58 AM
globenewswire.com logoEmergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
globenewswire.com - February 21 at 7:00 AM
finance.yahoo.com logoEmergent extends shelf life of opioid overdose reversal drug Narcan
finance.yahoo.com - January 17 at 3:45 PM
markets.businessinsider.com logoEmergent BioSolutions Bags 5-year Contract To Supply BioThrax To U.S. Defense Dept.
markets.businessinsider.com - January 11 at 2:03 PM
msn.com logoEmergent BioSolutions wins $235.8M DoD contract
msn.com - January 11 at 8:56 AM
finance.yahoo.com logoEmergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
finance.yahoo.com - January 11 at 8:56 AM
finance.yahoo.com logoEmergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
finance.yahoo.com - January 9 at 10:47 AM
seekingalpha.com logoEmergent BioSolutions: Q3 Numbers Leave Work To Be Done
seekingalpha.com - December 18 at 10:08 AM
marketbeat.com logoStockNews.com Upgrades Emergent BioSolutions (NYSE:EBS) to "Hold"
marketbeat.com - December 12 at 10:19 PM
finance.yahoo.com logoEmergent Biosolutions (EBS) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - December 11 at 2:48 PM
benzinga.com logoEmergent BioSolutions Stock (NYSE:EBS) Dividends: History, Yield and Dates
benzinga.com - December 3 at 2:20 PM
finance.yahoo.com logoEmergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
finance.yahoo.com - November 29 at 2:06 PM
finance.yahoo.com logoEmergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
finance.yahoo.com - November 28 at 8:01 AM
finance.yahoo.com logoEmergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
finance.yahoo.com - November 24 at 7:40 AM
seekingalpha.com logoEmergent BioSolutions: Meaningful Debt, But Narcan Should Grow
seekingalpha.com - November 23 at 9:50 AM
morningstar.com logoEmergent BioSolutions Inc EBS
morningstar.com - November 14 at 8:41 PM
markets.businessinsider.com logoMixed Financial Outlook for Emergent Biosolutions: Strong Narcan Sales Offset by Lowered Guidance and Increased Cash Usage
markets.businessinsider.com - November 10 at 6:52 AM
finance.yahoo.com logoEmergent BioSolutions Inc. (NYSE:EBS) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 9 at 5:42 PM
finance.yahoo.com logoEmergent BioSolutions Inc. (NYSE:EBS) institutional owners may be pleased with recent gains after 83% loss over the past year
finance.yahoo.com - November 9 at 12:42 PM
finance.yahoo.com logoEmergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 9 at 2:04 AM
bizjournals.com logoGaithersburg’s Emergent BioSolutions still betting on Narcan nasal spray, becoming ‘more agile’ following cuts
bizjournals.com - November 8 at 9:03 PM
finance.yahoo.com logoEmergent BioSolutions Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 8 at 9:03 PM
benzinga.com logoEarnings Preview For Emergent BioSolutions
benzinga.com - November 7 at 6:14 PM
finance.yahoo.com logoUPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023
finance.yahoo.com - October 30 at 5:56 PM
thestreet.com logoEmergent BioSolutions Rises On Unusually High Volume (EBS)
thestreet.com - October 28 at 12:33 AM
finance.yahoo.com logoEmergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023
finance.yahoo.com - October 19 at 10:12 AM
finance.yahoo.com logoEmergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic
finance.yahoo.com - October 16 at 8:43 AM
marketbeat.com logoNordea Investment Management AB Sells 49,117 Shares of Emergent BioSolutions Inc. (NYSE:EBS)
marketbeat.com - September 25 at 4:18 AM
finance.yahoo.com logoWhy Is Emergent Biosolutions (EBS) Down 22.6% Since Last Earnings Report?
finance.yahoo.com - September 7 at 6:45 PM
marketbeat.com logoCitigroup Inc. Raises Holdings in Emergent BioSolutions Inc. (NYSE:EBS)
marketbeat.com - September 5 at 4:52 AM
finance.yahoo.com logoEmergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
finance.yahoo.com - August 30 at 8:03 AM
msn.com logoBenchmark cuts Emergent BioSolutions to hold as company restructures
msn.com - August 29 at 10:02 PM
msn.com logoBenchmark Downgrades Emergent Biosolutions (EBS)
msn.com - August 29 at 10:02 PM
marketbeat.com logoRussell Investments Group Ltd. Sells 38,643 Shares of Emergent BioSolutions Inc. (NYSE:EBS)
marketbeat.com - August 29 at 4:22 AM
marketbeat.com logoEmergent BioSolutions Inc. (NYSE:EBS) Receives Average Recommendation of "Hold" from Analysts
marketbeat.com - August 28 at 6:26 AM
finance.yahoo.com logoMoody's downgrades Emergent BioSolutions' credit rating, citing unpredictable revenue outlook
finance.yahoo.com - August 23 at 3:32 PM
msn.com logoEmergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
msn.com - August 23 at 10:04 AM
finance.yahoo.com logoDown -28.45% in 4 Weeks, Here's Why You Should You Buy the Dip in Emergent Biosolutions (EBS)
finance.yahoo.com - August 17 at 4:47 PM
finance.yahoo.com logoSonnet (SONN) Up as Ovarian Cancer Drug Enters Clinical Study
finance.yahoo.com - August 17 at 4:47 PM
marketbeat.com logoEmergent BioSolutions (NYSE:EBS) Earns Sell Rating from Analysts at StockNews.com
marketbeat.com - August 17 at 4:24 AM
finance.yahoo.com logoDown -26.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Emergent Biosolutions (EBS)
finance.yahoo.com - August 16 at 6:18 PM
Get Emergent BioSolutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter.



EBS Media Mentions By Week

EBS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EBS
News Sentiment

0.36

0.69

Average
Medical
News Sentiment

EBS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EBS Articles
This Week

5

3

EBS Articles
Average Week

Get Emergent BioSolutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:EBS) was last updated on 2/29/2024 by MarketBeat.com Staff